Results 151 to 160 of about 2,682 (204)

A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters

open access: yesInternational Journal of Antimicrobial Agents, 2004
The efficacy of nitrofurazone-coated urinary catheter in inhibitory activity of catheter-associated urinary tract infection (CAUTI) was evaluated. The incidence rate and onset of CAUTI after catheterisation of standard silicone urinary catheters and ...
Sangeun Lee   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

DERMATITIS FOLLOWING THE USE OF NITROFURAZONE

Archives of Dermatology, 1948
A new group of bacteriostatic agents, the nitrofurans, of which 5-nitro-2-furaldehyde semicarbazone 1 is an example, has been found effective in the treatment of infected wounds. 2 To our knowledge, no examples of cutaneous sensitization to this particular group of drugs have been reported.
W R, HILL, W E, FLOOD
openaire   +2 more sources

Site of Reduction of Nitrofurazone by Bacteria

Nature, 1957
ANTIBACTERIAL, nitrofurans are reduced to the corresponding amino-compounds by Aerobacter aerogenes 1. The site of the reaction (in a different organism) is now shown to be the cytoplasmic membrane rather than the cell wall or cytoplasm. Lack of an enzyme system capable of effecting this reaction in the bacterial cell walls was not unexpected2.
A H, BECKETT, A E, ROBINSON
openaire   +2 more sources

NITROFURAZONE DERMATITIS FOLLOWING COITUS

Journal of the American Medical Association, 1954
Since the introduction of nitrofuran, derivatives as bacteriostatic agents, many cases of cutaneous sensitivity reactions to this group of drugs have been reported in the literature. Nitrofurazone (Furacin [5-nitro-2-furaldehyde semicarbazone]) is one member of this group that has been widely used during the last few years.
openaire   +2 more sources

OZENA: Streptomycin and Nitrofurazone Therapy

Archives of Otolaryngology - Head and Neck Surgery, 1950
OZENA is a well recognized clinical entity, first established by Fraenkel 1 in 1876, consisting of atrophic changes in the nasal mucosa, frequently involving the turbinate bones as well, crust formation and a uniquely offensive odor. Anosmia nearly always accompanies the condition.
openaire   +2 more sources

Nitrofurazone: Vas irrigation as adjunct in vasectomy

Urology, 1977
Intraoperative nitrofurazone vas injection has been utilized to hasten sterility in the immediate postoperative period. Clinically 100 outpatient vasectomies were performed in which nitrofurazone was utilized in a 1 mg. per milliliter concentration to irrigate the distal (penile) vas segment resulting in early attainment of azoospermia postoperatively ...
P S, Albert, J, Seebode
openaire   +2 more sources

IS NITROFURAZONE A POTENT SENSITIZER IN SURGICAL PATIENTS?

Plastic and Reconstructive Surgery, 2004
…
Yilmaz, S, Saydam, M, Seven, E
openaire   +3 more sources

Nitrofurazone: Vas Irrigation as an Adjunct in Vasectomy

Fertility and Sterility, 1978
Intraoperative vas irrigation with nitrofurazone utilized in a 1-mg/ml concentration can cause immediate sterility postoperatively. This irrigation procedure adds little time to the standard vasectomy and can easily be performed as an outpatient office procedure, minimizing time-consuming postoperative semen analyses.
P S, Albert, J, Seebode
openaire   +2 more sources

Contact allergy to nitrofurazone

Contact Dermatitis, 1994
Ballmer-Weber BK, Elsner P
openaire   +3 more sources

The effect of nitrofurazone on the thiamin status of chickens

Comparative Biochemistry and Physiology Part C: Comparative Pharmacology, 1983
Nitrofurazone, given orally at doses of 10 and 20 mg/kg for seven days, decreased the activity of erythrocyte transketolase (TK) and increased the activation of TK by thiamin pyrophosphate (TPP effect %). Nitrofurazone also decreased the feed intake and growth of the chickens, and increased the concentrations of lactate and pyruvate of their blood.
openaire   +2 more sources

Home - About - Disclaimer - Privacy